COVID-19 Vaccination Willingness and Hesitancy in Patients With Inflammatory Bowel Diseases: Analysis of Determinants in a National Survey of the Italian IBD Patients' Association
- Costantino A.
- Noviello D.
- Conforti F. S.
- Aloi M.
- Armuzzi A.
- Bossa F.
- Ficari F.
- Leone S.
- Manguso F.
- Mocci G.
- Orlando A.
- Pironi L.
- Radice S.
- Rizzello F.
- Tongiorgi A.
- Costantino C.
- Vecchi M.
- Caprioli F.
DOIAbstract
The coronavirus disease 2019 (COVID-19) pandemic has not finished yet, and the most promising option towards its ending is widespread vaccination. Because patients with inflammatory bowel diseases (IBDs), namely Crohn’s disease (CD) and ulcerative colitis (UC), often require immune-modifying treatment, which might increase the risk of opportunistic infection,1 their vaccination history for several infectious diseases is routinely checked, and when inadequate, vaccination is performed at diagnosis or ideally before immune suppressive treatment is started.1 However, IBD patients were not found to be at an increased risk of developing COVID-19 or of experiencing a more severe disease course.
Add to ORKG